Ignite Creation Date:
2024-05-06 @ 1:06 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03933761
Status:
WITHDRAWN
Last Update Posted:
2021-08-10
First Post:
2019-04-02
Brief Title:
Pamiparib in Fusion Positive Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA12 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor PARPI or Chemotherapy
Sponsor:
Australia New Zealand Gynaecological Oncology Group
Organization:
Australia New Zealand Gynaecological Oncology Group